(Q72516339)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Renal stone risk factors in patients with type IV renal tubular acidosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

main subject

renal tubular acidosis

1 reference

J Uribarri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

M S Oh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

C Y Pak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

publication date

1 June 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

27 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

784-787

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Pathophysiology of the syndrome of hyporeninemic hypoaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Uric acid nephrolithiasis in gout. Predisposing factors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

The metabolism defect responsible for uric acid stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Stone disease in hereditary distal renal tubular acidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

The preservation of urine samples for determination of renal stone risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Graphic display of urinary risk factors for renal stone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Low urinary citrate excretion in nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Uric acid saturation in calcium nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

The calciuria of increased fixed acid production in humans: Evidence against a role for parathyroid hormone and 1,25(OH)2-vitamin D

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

The effects of fluoroacetate, malonate and acid-base balance on the renal disposal of citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Inhibition by citrate of spontaneous precipitation of calcium oxalate in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium Urate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

Hyperuricosuric calcium oxalate nephrolithiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980129-6

1 reference

7 January 2021

10.1016/S0272-6386(12)80129-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8203358%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference